IN186768B - - Google Patents

Info

Publication number
IN186768B
IN186768B IN2893DE1996A IN186768B IN 186768 B IN186768 B IN 186768B IN 2893DE1996 A IN2893DE1996 A IN 2893DE1996A IN 186768 B IN186768 B IN 186768B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Herve Bouchard
Alain Commercon
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Priority to IN419DE2000 priority Critical patent/IN188680B/en
Publication of IN186768B publication Critical patent/IN186768B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN2893DE1996 1995-12-22 1996-12-20 IN186768B (enFirst)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN419DE2000 IN188680B (enFirst) 1995-12-22 2000-04-10

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9515379A FR2742751B1 (fr) 1995-12-22 1995-12-22 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
IN186768B true IN186768B (enFirst) 2001-11-03

Family

ID=9485871

Family Applications (4)

Application Number Title Priority Date Filing Date
IN2893DE1996 IN186768B (enFirst) 1995-12-22 1996-12-20
IN419DE2000 IN188680B (enFirst) 1995-12-22 2000-04-10
IN420DE2000 IN188469B (enFirst) 1995-12-22 2000-04-10
IN421DE2000 IN188470B (enFirst) 1995-12-22 2000-04-10

Family Applications After (3)

Application Number Title Priority Date Filing Date
IN419DE2000 IN188680B (enFirst) 1995-12-22 2000-04-10
IN420DE2000 IN188469B (enFirst) 1995-12-22 2000-04-10
IN421DE2000 IN188470B (enFirst) 1995-12-22 2000-04-10

Country Status (40)

Country Link
US (1) US5728849A (enFirst)
EP (1) EP0876362B1 (enFirst)
JP (1) JP3953106B2 (enFirst)
KR (1) KR100500351B1 (enFirst)
CN (1) CN1103766C (enFirst)
AR (1) AR005197A1 (enFirst)
AT (1) ATE250593T1 (enFirst)
AU (1) AU712597B2 (enFirst)
BG (1) BG63204B1 (enFirst)
BR (1) BR9612135A (enFirst)
CA (1) CA2238884C (enFirst)
CO (1) CO4520184A1 (enFirst)
CZ (1) CZ294972B6 (enFirst)
DE (1) DE69630145T2 (enFirst)
DK (1) DK0876362T3 (enFirst)
DZ (1) DZ2149A1 (enFirst)
EA (1) EA001533B1 (enFirst)
ES (1) ES2202490T3 (enFirst)
FR (1) FR2742751B1 (enFirst)
HU (1) HU225032B1 (enFirst)
IL (1) IL124994A (enFirst)
IN (4) IN186768B (enFirst)
MA (1) MA26412A1 (enFirst)
MX (1) MX9804688A (enFirst)
MY (1) MY113934A (enFirst)
NO (1) NO317358B1 (enFirst)
NZ (1) NZ324337A (enFirst)
OA (1) OA10700A (enFirst)
PE (1) PE25198A1 (enFirst)
PL (1) PL189311B1 (enFirst)
PT (1) PT876362E (enFirst)
RO (1) RO116194B1 (enFirst)
SK (1) SK282835B6 (enFirst)
TN (1) TNSN96169A1 (enFirst)
TR (1) TR199801179T2 (enFirst)
TW (1) TW371659B (enFirst)
UA (1) UA48205C2 (enFirst)
UY (1) UY24386A1 (enFirst)
WO (1) WO1997023473A1 (enFirst)
ZA (1) ZA9610737B (enFirst)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
RU2264400C2 (ru) 2000-02-02 2005-11-20 Флорида Стейт Юниверсити Рисерч Фаундейшн, Инк. Таксан, фармацевтическая композиция на его основе и способ ингибирования роста опухоли
HRPK20110926B3 (hr) * 2001-02-24 2013-05-31 Boehringer Ingelheim Pharma Gmbh & Co.Kg. Derivati ksantina, njihova proizvodnja i upotreba kao lijekova
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
WO2004103344A1 (en) * 2003-05-20 2004-12-02 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
EP1669358A1 (en) * 2004-12-07 2006-06-14 Aventis Pharma S.A. Cytotoxic agents comprising new taxanes
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
CA2873524C (en) 2006-05-04 2018-02-20 Boehringer Ingelheim International Gmbh A polymeric form of 1-((4-methyl-quinazolin-2-yl)methyl)-3-7-(2-butyn-1-yl)-8-(3-(r)-aminopiperidin-1-yl)xanthine
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
CN101784278A (zh) * 2007-08-17 2010-07-21 贝林格尔.英格海姆国际有限公司 用于治疗fab-相关的疾病的嘌呤衍生物
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
MX370599B (es) * 2008-08-15 2019-12-18 Boehringer Ingelheim Int Derivados de purina para su uso en el tratamiento de enfermedades relacionadas con fab.
CN102149407A (zh) 2008-09-10 2011-08-10 贝林格尔.英格海姆国际有限公司 治疗糖尿病和相关病症的组合疗法
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
MX2011006713A (es) 2008-12-23 2011-07-13 Boehringer Ingelheim Int Formas salinas de compuesto organico.
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
MX364651B (es) 2009-11-27 2019-05-03 Boehringer Ingelheim Int Gmbh Star Inhibidores de dpp-iv, tales como la linagliptina, y composiciones farmacéuticas o combinaciones que comprenden los mismos, para usarse en el tratamiento de pacientes diabéticos tipificados genéticamente.
BR112012028136A2 (pt) 2010-05-05 2016-08-09 Boehringer Ingelheim Int terapia de combinaçao
MX2012014247A (es) 2010-06-24 2013-01-18 Boehringer Ingelheim Int Terapia para la diabetes.
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
US8962636B2 (en) 2011-07-15 2015-02-24 Boehringer Ingelheim International Gmbh Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
JP6218811B2 (ja) 2012-05-14 2017-10-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Sirs及び/又は敗血症の治療に用いるdpp−4阻害薬としてのキサンチン誘導体
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
ES2701076T3 (es) 2012-11-24 2019-02-20 Hangzhou Dac Biotech Co Ltd Enlazadores hidrofílicos y sus usos para la conjugación de fármacos a las moléculas que se unen a las células
FR3010839B1 (fr) * 2013-09-17 2017-04-21 Schneider Electric Ind Sas Dispositif de raccordement electrique d'au moins un conducteur dans une borne appartenant a un appareil electrique
CN114262344A (zh) 2014-02-28 2022-04-01 杭州多禧生物科技有限公司 带电荷链接体及其在共轭反应上的应用
US9526728B2 (en) 2014-02-28 2016-12-27 Boehringer Ingelheim International Gmbh Medical use of a DPP-4 inhibitor
EP3319936B1 (en) 2015-07-12 2025-12-17 Hangzhou Dac Biotech Co., Ltd. Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
CA3022202A1 (en) 2016-06-10 2017-12-14 Boehringer Ingelheim International Gmbh Combinations of linagliptin and metformin
KR20220147719A (ko) 2016-11-14 2022-11-03 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
EP4426727A2 (en) 2021-11-03 2024-09-11 Hangzhou Dac Biotech Co., Ltd. Specific conjugation of an antibody

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017724C1 (ru) * 1990-07-12 1994-08-15 Дзе Юниверсити оф Канзас Способ получения производных таксола
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
FR2678930B1 (fr) * 1991-07-10 1995-01-13 Rhone Poulenc Rorer Sa Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
DE69325454T2 (de) * 1992-04-17 2000-01-20 Abbott Laboratories, Abbott Park Taxol-derivate
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
MX9307777A (es) * 1992-12-15 1994-07-29 Upjohn Co 7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.

Also Published As

Publication number Publication date
WO1997023473A1 (fr) 1997-07-03
SK85398A3 (en) 1998-11-04
DE69630145T2 (de) 2004-07-15
CA2238884A1 (fr) 1997-07-03
AU1180997A (en) 1997-07-17
PL327405A1 (en) 1998-12-07
BG63204B1 (bg) 2001-06-29
EA199800588A1 (ru) 1998-12-24
JP3953106B2 (ja) 2007-08-08
TW371659B (en) 1999-10-11
PE25198A1 (es) 1998-05-10
AU712597B2 (en) 1999-11-11
IN188680B (enFirst) 2002-10-26
US5728849A (en) 1998-03-17
SK282835B6 (sk) 2002-12-03
EP0876362B1 (fr) 2003-09-24
EA001533B1 (ru) 2001-04-23
KR100500351B1 (ko) 2005-12-21
BR9612135A (pt) 1999-07-13
DK0876362T3 (da) 2004-02-02
FR2742751A1 (fr) 1997-06-27
MX9804688A (es) 1998-10-31
CO4520184A1 (es) 1997-10-15
ATE250593T1 (de) 2003-10-15
NO982580D0 (no) 1998-06-05
BG102569A (en) 1999-04-30
HK1017895A1 (en) 1999-12-03
IL124994A0 (en) 1999-01-26
UY24386A1 (es) 2001-08-27
CZ294972B6 (cs) 2005-04-13
IL124994A (en) 2000-12-06
NZ324337A (en) 2000-03-27
OA10700A (fr) 2002-11-27
PT876362E (pt) 2004-02-27
PL189311B1 (pl) 2005-07-29
IN188470B (enFirst) 2002-09-28
NO982580L (no) 1998-06-05
CZ196198A3 (cs) 1998-09-16
TNSN96169A1 (fr) 2005-03-15
HUP9904046A3 (en) 2001-08-28
CN1103766C (zh) 2003-03-26
HU225032B1 (en) 2006-05-29
EP0876362A1 (fr) 1998-11-11
HUP9904046A1 (hu) 2001-04-28
TR199801179T2 (xx) 1998-10-21
DE69630145D1 (de) 2003-10-30
FR2742751B1 (fr) 1998-01-30
MA26412A1 (fr) 2004-12-20
UA48205C2 (uk) 2002-08-15
AR005197A1 (es) 1999-04-14
ES2202490T3 (es) 2004-04-01
NO317358B1 (no) 2004-10-18
ZA9610737B (en) 1997-06-27
DZ2149A1 (fr) 2002-10-23
IN188469B (enFirst) 2002-09-28
CA2238884C (fr) 2007-02-06
RO116194B1 (ro) 2000-11-30
MY113934A (en) 2002-06-29
CN1205697A (zh) 1999-01-20
JP2000502671A (ja) 2000-03-07
KR19990076680A (ko) 1999-10-15

Similar Documents

Publication Publication Date Title
IN187897B (enFirst)
IN182130B (enFirst)
BRPI9612258B1 (enFirst)
BRPI9612138B1 (enFirst)
IN188680B (enFirst)
FR2729528B1 (enFirst)
IN182137B (enFirst)
IN187841B (enFirst)
FR2731335B3 (enFirst)
IN182495B (enFirst)
IN181407B (enFirst)
IN181939B (enFirst)
ECSDI950273S (enFirst)
IN183297B (enFirst)
IN185632B (enFirst)
IN187250B (enFirst)
CN3035869S (enFirst)
CN3034591S (enFirst)
CN3036463S (enFirst)
CN3035871S (enFirst)
CN3035870S (enFirst)
CN3036648S (enFirst)
CN3035868S (enFirst)
CN3035323S (enFirst)
CN3035300S (enFirst)